Lubeya Mwansa Ketty, Mwanahamuntu Mulindi, Chibwesha Carla J, Mukosha Moses, Kawonga Mary
Department of Obstetrics and Gynaecology, School of Medicine, University of Zambia, Lusaka 10101, Zambia.
Women and Newborn Hospital, University Teaching Hospitals, Lusaka 10101, Zambia.
Vaccines (Basel). 2024 May 15;12(5):542. doi: 10.3390/vaccines12050542.
The human papillomavirus (HPV) vaccine is effective in cervical cancer prevention. However, many barriers to uptake exist and strategies to overcome them are needed. Therefore, this study aimed to select and tailor implementation strategies to barriers identified by multiple stakeholders in Zambia. The study was conducted in Lusaka district between January and February 2023. Participants were purposively sampled from three stakeholder groups namely, adolescent girls, parents, and teachers and healthcare workers. With each of the stakeholders' groups (10-13 participants per group), we used the nominal group technique to gain consensus to tailor feasible and acceptable implementation strategies for mitigating the identified contextual barriers. The identified barriers included low levels of knowledge and awareness about the HPV vaccine, being out of school, poor community sensitisation, lack of parental consent to vaccinate daughters, and myths and misinformation about the HPV vaccine. The lack of knowledge and awareness of the HPV vaccine was a common barrier across the three groups. Tailored strategies included conducting educational meetings and consensus-building meetings, using mass media, changing service sites, re-examining implementation, and involving patients/consumers and their relatives. Our study contributes to the available evidence on the process of selecting and tailoring implementation strategies to overcome contextual barriers. Policymakers should consider these tailored strategies to mitigate barriers and improve HPV vaccine uptake.
人乳头瘤病毒(HPV)疫苗在预防宫颈癌方面是有效的。然而,疫苗接种存在许多障碍,需要采取策略来克服这些障碍。因此,本研究旨在选择并定制针对赞比亚多个利益相关者所确定障碍的实施策略。该研究于2023年1月至2月在卢萨卡区进行。参与者是从三个利益相关者群体中有意抽样选取的,即青春期女孩、家长、教师以及医护人员。针对每个利益相关者群体(每组10 - 13名参与者),我们使用名义小组技术达成共识,以定制可行且可接受的实施策略,来减轻已确定的背景障碍。已确定的障碍包括对HPV疫苗的知识和认知水平低、辍学、社区宣传不足、缺乏家长同意为女儿接种疫苗,以及关于HPV疫苗的谣言和错误信息。对HPV疫苗缺乏知识和认知是这三个群体共有的障碍。定制的策略包括召开教育会议和建立共识会议、利用大众媒体、改变服务地点、重新审视实施情况,以及让患者/消费者及其亲属参与进来。我们的研究为选择和定制实施策略以克服背景障碍的过程提供了现有证据。政策制定者应考虑这些定制策略,以减轻障碍并提高HPV疫苗的接种率。